ResMed Inc. (RMD)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 219.97 |
| Open | 219.82 |
| Bid | 0.00 x 900 |
| Ask | 238.28 x 900 |
| Day's Range | 217.53 - 220.04 |
| 52 Week Range | 132.24 - 229.97 |
| Volume | |
| Avg. Volume | 1,103,320 |
| Market Cap | 32.109B |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | 33.68 |
| EPS (TTM) | 6.49 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | 1.92 (0.88%) |
| Ex-Dividend Date | May 08, 2024 |
| 1y Target Est | 212.34 |
ZacksHaemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
ZacksMaravai (MRVI) Advances in RNA Research With New Collaboration
Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.
ZacksHaemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?
Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.
© 2024 Yahoo. All rights reserved.